|
UBE2R2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.492200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.258610E-03 |
| Normal-vs-Stage2 |
7.231600E-01 |
| Normal-vs-Stage3 |
7.737800E-01 |
| Normal-vs-Stage4 |
6.039600E-01 |
| Stage1-vs-Stage2 |
7.479700E-02 |
| Stage1-vs-Stage3 |
1.815770E-03 |
| Stage1-vs-Stage4 |
1.604790E-01 |
| Stage2-vs-Stage3 |
5.917400E-01 |
| Stage2-vs-Stage4 |
8.579800E-01 |
| Stage3-vs-Stage4 |
4.935000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.489900E-02 |
| Normal-vs-AfricanAmerican |
7.786600E-01 |
| Normal-vs-Asian |
4.208600E-01 |
| Caucasian-vs-AfricanAmerican |
1.341370E-01 |
| Caucasian-vs-Asian |
6.571400E-01 |
| AfricanAmerican-vs-Asian |
2.617200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.415800E-01 |
| Normal-vs-Female |
3.357700E-03 |
| Male-vs-Female |
2.328200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.761000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.346270E-02 |
| Normal-vs-Age(61-80Yrs) |
2.714400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.923600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.704400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.146600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.683800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.390210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.320560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.414600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.037050E-03 |
| Normal-vs-Grade 2 |
6.173300E-04 |
| Normal-vs-Grade 3 |
7.636200E-01 |
| Normal-vs-Grade 4 |
9.054800E-01 |
| Grade 1-vs-Grade 2 |
2.952000E-01 |
| Grade 1-vs-Grade 3 |
3.202200E-02 |
| Grade 1-vs-Grade 4 |
1.883990E-02 |
| Grade 2-vs-Grade 3 |
1.284820E-03 |
| Grade 2-vs-Grade 4 |
7.252400E-02 |
| Grade 3-vs-Grade 4 |
9.589200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.84510000015237E-07 |
| Normal-vs-ccB subtype |
4.691800E-01 |
| ccA subtype-vs-ccB subtype |
1.02370000032437E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.070640E-01 |
| Normal-vs-N1 |
6.868600E-01 |
| N0-vs-N1 |
8.633200E-01 |
|
|
